Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?

  1. Eguren-Santamaria, I.
  2. Sanmamed, M.F.
  3. Gil-Bazo, I.
Aldizkaria:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Argitalpen urtea: 2020

Alea: 15

Zenbakia: 4

Orrialdeak: 489-492

Mota: Editoriala

DOI: 10.1016/J.JTHO.2020.02.003 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus